4[1]Sulch D, Melbourn A, Perez l, et al. Integrated care pathways and quality of life on a stroke rehabilitation unit. Stroke, 2002, 33:1600-1604.
5[2]Marler JR, Goldstein LB. Medicine, stroke-tPA and the clinic. Science, 2003, 301: 1677.
6[3]Wang X, Lee SR, Arai K, et al, Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med, 2003, 9: 1313-1317.
7[4]Aarts M, Liu Y, Liu L, et al. Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science, 2002, 298: 846-850.
8[5]Gribkoff VK, Starrett JE Jr, Dworetzky SI, et al. Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med, 2001, 7: 471-477.
9[6]Justicia C, Perez-Asensio FJ, Burguete MC, et al. Administration of transforming growth factor -alpha reduces infarct volume after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Mehab, 2001, 21: 1097-1104.
10[7]Marcheselli VL, Hong S, Lukiw WJ, et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem, 2003, 278: 43807-43817.
